Published • loading... • Updated
AMC Bio Acquires CYCLOPE for Broad-Spectrum Antivirals
Summary by Born2Invest
1 Articles
1 Articles
AMC Bio Acquires CYCLOPE for Broad-Spectrum Antivirals
AMC Bio has acquired the CYCLOPE project from French technology-transfer partners to advance a potential antiviral treatment targeting dengue, Zika, chikungunya and West Nile virus. Developed through collaboration between chemists and virologists, the programme aims to target a host-cell mechanism shared by several viruses. Preclinical development remains necessary before clinical efficacy can be established.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
